Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Brain and Spinal Cord Cancer
  •  Central Nervous System Tumors
  •  Thoracic Oncology
  •  Radiation Oncology
  •  Bladder Cancer
  •  Prostate Cancer
  •  Ovarian Cancer
  •  Colon Cancer

Abstract

Citation: Clin Oncol. 2021;6(1):1790.DOI: 10.25107/2474-1663.1790

A Case Report of Primary Jejunal T-Lymphoblastic Lymphoma and a Review of the Literature

Tadashi Yamamoto, Haruko Tashiro, Koichiro Abe, Ritsu Sumiyoshi, Takuji Matsuo, Sumiko Saito, Kensuke Matsumoto, Jun Ooi, Yudai Uchida, Yuko Sasajima and Naoki Shirafuji

Department of Hematology/Oncology, Teikyo University School of Medicine, Japan
Department of Gastroenterology, Teikyo University School of Medicine, Japan
Department of Neurology, Teikyo University School of Medicine, Japan
Division of Pathology, Teikyo University Hospital, Japan

*Correspondance to: Naoki Shirafuji 

 PDF  Full Text Case Report | Open Access

Abstract:

We report a 29-year-old male who developed primary jejunal T-Lymphoblastic Lymphoma (T-LBL). The patient was admitted to our hospital due to epigastralgia and back pain. An abdominal contrastenhanced Computed Tomography (CT) showed thickness of jejunal wall and enlargement of perijejunal lymph nodes. A gastrointestinal endoscopy showed an ulcerative tumor with bleeding at
proximal end of jejunum beyond the Treitz ligament. A 18F-Fluorodeoxyglucose (FDG) -positron emission tomography/CT showed abnormal FDG uptake in jejunum, peri-jejunum lymph nodes, and left supraclavicular fossa lymph node as well as mediastinal and para-aortic lymph nodes. The tumor biopsy revealed middle to large sized abnormal lymphoblasts’ proliferation which were
positive for CD3, CD5, CD10, CD79a, BCL2, and TdT, and negative for CD4, CD8, and CD20. We diagnosed him with T-LBL (Lugano stage IV). After administration of three courses of alternating hyper-CVAD with high-dose methotrexate and cytarabine he underwent umbilical cord blood transplantation at 1st Complete Remission (CR) and has maintained CR for more than 33 months.
Intestinal T-LBL is very rare and has poor prognosis. To understand this disease, accumulating each case precisely and further investigation are very important.

Keywords:

T-lymphoblastic lymphoma; Jejunum; Umbilical cord blood transplantation

Cite the Article:

Yamamoto T, Tashiro H, Abe K, Sumiyoshi R, Matsuo T, Saito S, et al. A Case Report of Primary Jejunal T-Lymphoblastic Lymphoma and a Review of the Literature. Clin Oncol. 2021;6:1790..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Inducing Anti-Tumor Immune Responses in Lung Adenocarcinoma: High-Dose of Ascorbic Acid Combined with Arginine and Magnesium Sulfate
 Abstract  PDF  Full Text
Towards Liver: Selected Aspects of Uveal Melanoma Metastasis
 Abstract  PDF  Full Text
View More...